How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―

Abstract

Participants Japanese patients with PH (including PAH and CTEPH) aged ≥18 years were recruited to the study. Patients were excluded from the study if their World Health Organization (WHO) functional class was expected to change or PHspecific treatment was expected to start or change during the study. In addition, patients who were unable to understand and respond to the questionnaire due to comorbidities were excluded from the study. Data Collection A questionnaire investigating the effects of COVID-19 was administered to patients between 17 and 23 May 2020 at a center

Economic Burden in Treated Japanese Patients with Relapsed/Refractory Large B-Cell Lymphoma

“…Global studies of oncology and COVID-19 also suggest the use of telehealth, avoidance of non-essential visits, and minimization of exposure periods [43][44][45]48]. Although there is some evidence of changes in medical encounters in other chronic disease practices in Japan [49][50][51] and increased use of telemedicine in some centers [52], the widespread use of telemedicine and treatment changes in oncology remains limited and cannot be well observed in this claims database study.…”

COVID-19 pandemic modifies temperature and heat-related illness ambulance transport association in Japan: a nationwide observational study

“…The increased remote working environments as well as the availability of alternative services such as telemedicine, home/food deliveries, may have potentially reduced the ambient exposure of the population [ 41 ]. Early in the pandemic, on March 2020, the Japanese government encouraged firms to integrate a work-from-home setting to avoid cluster infections within workplaces.…”

Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

“…After COVID-19 pandemic onset and diffusion, the rapid involvement of millions of people worldwide forced local and national healthcare systems to adopt telemedicine for ensuring baseline and, in some selected cases, advanced healthcare supports. This was the case for several chronic progressive cardiovascular diseases, such as pulmonary hypertension [46], congestive heart failure [47][48][49] and chronic kidney disease [50], but also for non-cardiovascular diseases, mostly onco-hematologic diseases [51,52]. Among these conditions, essential hypertension represents an ideal target for telemedicine, since: (1) it affects In addition, participants with inadequate BP control at recruitment might gain more benefits with mHealth intervention [63] millions of people across all age, gender, and ethnic groups almost in all countries all over the world; (2) it requires periodic assessment of both vital signs (i.e., BP levels) and adherence to prescribed interventions (life-style changes and/or drug therapies); it is highly affected and positively influenced by frequent interactions between patients and health care providers from both educational and therapeutic point of views.…”